•      
    • Access >
    • |
    • Health Professionals
News
  • July 15, 2008
  •  - 
  • Amsterdam
Agendia and Ferrer announce for sales of cancer diagnostic services in four major european markets

Agendia and Ferrer announcs exclusive agreement for sales of cancer diagnostic services in four major european markets

AMSTERDAM, The Netherlands and BARCELONA, Spain, July...   (read +) 

  • December 14, 2007
  •  - 
  • Amsterdam, The Netherlands
Lancet Oncology Study shows benefits of MammaPrint

December 14, 2007 - Study Shows MammaPrint® Breast Cancer Test Provides Benefits to Patients from Personalized Treatment Regimen

-- New Lancet Oncology publication provides important insights on the use of MammaPrint® breast cancer prognosis test in clinical practice...   (read +) 

  • October 29, 2007
  •  - 
  • Amsterdam, The Netherlands
Agendia appoints Clinical and Scientific Advisory Board

October 29, 2007 - Agendia BV appoints Clinical and Scientific Advisory Board. Six eminent cancer researchers advise Agendia

Amsterdam, The Netherlands October 29,...   (read +) 

  • October 25, 2007
  •  - 
  • London
Frost & Sullivan award for MammaPrint

October 25, 2007 -   Frost & Sullivan Award Recognizes Agendia BV’s Pioneering MammaPrint® in the Biomarker-based Breast Cancer Diagnostics Arena

LONDON--(BUSINESS WIRE)--The 2007 Frost & Sullivan European Product Innovation Award in the field of biomarker-based breast cancer...   (read +) 

  • October 22, 2007
Agendia announces that it's Chief Research Officer Laura van't Veer has received a 2007 Breast Cancer Research Foundation Award

October 25, 2007 -   Agendia BV announces that its Chief Research Officer Laura van ’t Veer has received a 2007 Breast Cancer Research Foundation Award

Amsterdam, the Netherlands October 25th, 2007
Agendia BV, a world leader in the rapidly evolving field of cancer...   (read +) 

  • August 12, 2007
  •  - 
  • Barcelona, Spain
Ferrer to distribute MammaPrint and CupPrint in Spain

Agendia B.V. and Ferrer in Code, a subsidiary of Ferrer, one of Spains leading pharmaceutical companies, have entered into an exclusive agreement for distribution of the Agendia services MammaPrint and CupPrint in Spain.

MammaPrint is a new highly accurate gene expression profiling...   (read +) 

Ferrer inCode  |  Diagonal, 549 5ª floor, E-08029 Barcelona  |  Phone. +34 93 600 37 00  |  Fax: +34 93 490 70 78